The INVOS™ system

A Clear Choice Supported by Clinical Data

  • The only cerebral oximeter on the market to be tested and validated under varying levels of CO2 to ensure measurement sensitivity during changing levels of blood volume under the sensor.1
  • Provides reliable, real-time data (what some manufacturers call “absolute”) in patients > 2.5 kg.
  • The only cerebral/somatic oximeter with rigorous, peer-reviewed clinical investigations demonstrating ability to improve patient outcomes.2,3
  • More than 1,000 clinical studies (more than 600 which are peer-reviewed) show the INVOS™ system as the clinical standard.
  • Three published, randomised, controlled trials have established the clinical value of the INVOS™ system to aid clinicians in improving patient outcomes.2,3,3 
  • The only device with a claim for improved outcomes after surgery.2,3,5
  • 1. Kim M, Ward D, Cartwright C, et al. Estimation of jugular venous O2 saturation from cerebral oximetry or arterial O2 saturation during isocapnic hypoxia. J Clin Monit Comput. 2000;16(3):191-99.
  • 2. Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007;104(1):51-58
  • 3. Casati A, Fanelli G, Pietropaoli P, et al. Continuous monitoring of cerebral oxygen saturation in elderly patients undergoing major abdominal surgery minimizes brain exposure to potential hypoxia. Anesth Analg. 2005;101(3):740-747.
  • 5. Goldman S, Sutter F, Ferdinand F, Trace C. Optimizing intraoperative cerebral oxygen delivery using noninvasive cerebral oximetry decreases the incidence of stroke for cardiac surgical patients. Heart Surg Forum. 2004;7(5):E376-381.